ARCHIVES

Myriad In Partnership To Market Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million

April 12, 1985